• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Researchers clash over AAA screening's worth

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 9
Volume 31
Issue 9

Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.

Two European studies published on the same day have reached opposite conclusions about the cost-effectiveness of ultrasound screening exams for abdominal aortic aneurysm.

Researchers in the U.K. came to a positive conclusion about the exam's cost-effectiveness based on nearly 70,000 subjects enrolled in the Multicenter Aneurysm Screening Study (MASS). A cost/benefit analysis showed average per-life-year gains below the National Health Service's benchmark of £25,000. Danish investigators, on the other hand, reported negative findings using a mathematical model and data from the literature and the Danish Vascular Registry to estimate costs and outcomes for a hypothetical population of Danish men aged 65 from screening to death. Their estimates showed the cost of screening per quality adjusted life year was $71,160, well beyond the local accepted benchmark of $49,530. Both studies were published online June 26 in the British Medical Journal.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.